When patients were divided into subgroups based on MUC1 expression, MUC2 expression, or MUC5AC expression, there were no significant differences in terms of age, sex, tumour grade, tumour size, N stage, tumour location, vascular invasion, and diabetes mellitus history. This evidence concerns the gene MUC5AC and neoplasm.